Skip to content

Research Transparency Panel Meeting Summary

Flatiron, on behalf of Johnson & Johnson

3rd December 2024

Data Access Proposal Request


Flatiron Health UK RWD Products

  • Non-small cell lung cancer


Attendees

Flatiron Health UK

  • Adam Manhi (chair)

  • Emma Salib (programme manager)

Research Transparency Panel

  • Jennifer McCaffery (lay)

  • Hayley Hall (lay)

  • Sonia Patton (patient)

  • Trishna Bharadia (patient)

  • Yanrong Jiang (clinical)


Conflicts of interest

No conflicts declared by panel


Decision outcome

Approved


Summary of discussion

  • Lay summary provides strong explanation of disease background and unmet need.

  • Good and concise description of data that will be analysed, type of analysis, objectives and outputs.

  • Clear distinction between this data access request (fit-for-purpose assessment) and potential downstream analyses to support a wider set of use cases.

  • Clear that J&J will only receive outputs of Flatiron’s analysis and no access to data.

  • The panel raised several comments on other aspects of the application including:

    • The content could have been written in more lay terms.

    • Further detail could have been provided on what patient demographic and clinical characteristics would be analysed.

    • Overall the panel felt this approach of assessing the database was likely to lead to a more focused future data access request from J&J.

Get in touch

Connect with our team if you have any questions.